Warren Stone was appointed President and Chief Operating Officer of NeoGenomics in April 2025. He joined Neo in November 2022 as President, Clinical Services and later became Chief Commercial Officer.
Warren is a highly accomplished enterprise leader with extensive global experience in the life science and diagnostic sectors, who most recently served as President of Americas at Ortho Clinical Diagnostics (now QuidelOrtho).
As a hands-on leader, Warren championed the development of an organizational growth culture and digital transformation of systems and tools, including a hybrid/digital go-to-market deployment model, delivering productivity, margin expansion, and accelerated revenue growth. With an emphasis on customer experience, Warren’s team won an independent industry ServiceTrak™ award for the Best Pre/Post-Sales and Customer Success in 2021 and 2022.
Before joining Ortho Clinical, Warren served as Senior Vice President of Research Americas for MilliporeSigma, where he developed a commercial growth strategy, advancing the business 40% above the market. He also drove a cross-functional digital transformation to address customer needs, resulting in more than $200 million in incremental revenue in 2.5 years.